On January 13, 2022 at 18:42, davidcasemore said...
I guess you didn't read what I said. I will try again:
When a patent on a drug ends, and the drug is then available as a generic, the pharmaceutical company that created the original drug can make just a slight change in the chemical make-up, rename it, and say it's for treating whatever new disease they want ("It's not just for horses anymore! Now it treats COVID!).
The fact that they aren't doing that (and losing millions of dollars) is because it does not work for treating COVID.
The generic can still be produced and used.
And works 100% better than “go home and see if you are better in a few days” (AKA a hope and a prayer).
